Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit

Nabil Miled, Ying Yan, Wai Ching Hon, Olga Perisic, Marketa Zvelebil, Yuval Inbar, Dina Schneidman-Duhovny, Haim J. Wolfson, Jonathan M. Backer, Roger L. Williams

Research output: Contribution to journalArticle

267 Citations (Scopus)

Abstract

Many human cancers involve up-regulation of the phosphoinositide 3-kinase PI3Ka, with oncogenic mutations identified in both the p110α catalytic and the p85α regulatory subunits. We used crystallographic and biochemical approaches to gain insight into activating mutations in two noncatalytic p110α domains - the adaptor-binding and the helical domains. A structure of the adaptor-binding domain of p110α in a complex with the p85α inter-Src homology 2 (inter-SH2) domain shows that oncogenic mutations in the adaptor-binding domain are not at the inter-SH2 interface but in a polar surface patch that is a plausible docking site for other domains in the holo p110/p85 complex. We also examined helical domain mutations and found that the Glu 545 to Lys545 (E545K) oncogenic mutant disrupts an inhibitory charge-charge interaction with the p85 N-terminal SH2 domain. These studies extend our understanding of the architecture of PI3Ks and provide insight into how two classes of mutations that cause a gain in function can lead to cancer.

Original languageEnglish (US)
Pages (from-to)239-242
Number of pages4
JournalScience
Volume317
Issue number5835
DOIs
StatePublished - Jul 13 2007

Fingerprint

1-Phosphatidylinositol 4-Kinase
Catalytic Domain
Mutation
src Homology Domains
Neoplasms
Phosphatidylinositol 3-Kinases
Up-Regulation

ASJC Scopus subject areas

  • General

Cite this

Miled, N., Yan, Y., Hon, W. C., Perisic, O., Zvelebil, M., Inbar, Y., ... Williams, R. L. (2007). Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science, 317(5835), 239-242. https://doi.org/10.1126/science.1135394

Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. / Miled, Nabil; Yan, Ying; Hon, Wai Ching; Perisic, Olga; Zvelebil, Marketa; Inbar, Yuval; Schneidman-Duhovny, Dina; Wolfson, Haim J.; Backer, Jonathan M.; Williams, Roger L.

In: Science, Vol. 317, No. 5835, 13.07.2007, p. 239-242.

Research output: Contribution to journalArticle

Miled, N, Yan, Y, Hon, WC, Perisic, O, Zvelebil, M, Inbar, Y, Schneidman-Duhovny, D, Wolfson, HJ, Backer, JM & Williams, RL 2007, 'Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit', Science, vol. 317, no. 5835, pp. 239-242. https://doi.org/10.1126/science.1135394
Miled N, Yan Y, Hon WC, Perisic O, Zvelebil M, Inbar Y et al. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science. 2007 Jul 13;317(5835):239-242. https://doi.org/10.1126/science.1135394
Miled, Nabil ; Yan, Ying ; Hon, Wai Ching ; Perisic, Olga ; Zvelebil, Marketa ; Inbar, Yuval ; Schneidman-Duhovny, Dina ; Wolfson, Haim J. ; Backer, Jonathan M. ; Williams, Roger L. / Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. In: Science. 2007 ; Vol. 317, No. 5835. pp. 239-242.
@article{21cab8f085d448d9bbb49c9726221ce6,
title = "Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit",
abstract = "Many human cancers involve up-regulation of the phosphoinositide 3-kinase PI3Ka, with oncogenic mutations identified in both the p110α catalytic and the p85α regulatory subunits. We used crystallographic and biochemical approaches to gain insight into activating mutations in two noncatalytic p110α domains - the adaptor-binding and the helical domains. A structure of the adaptor-binding domain of p110α in a complex with the p85α inter-Src homology 2 (inter-SH2) domain shows that oncogenic mutations in the adaptor-binding domain are not at the inter-SH2 interface but in a polar surface patch that is a plausible docking site for other domains in the holo p110/p85 complex. We also examined helical domain mutations and found that the Glu 545 to Lys545 (E545K) oncogenic mutant disrupts an inhibitory charge-charge interaction with the p85 N-terminal SH2 domain. These studies extend our understanding of the architecture of PI3Ks and provide insight into how two classes of mutations that cause a gain in function can lead to cancer.",
author = "Nabil Miled and Ying Yan and Hon, {Wai Ching} and Olga Perisic and Marketa Zvelebil and Yuval Inbar and Dina Schneidman-Duhovny and Wolfson, {Haim J.} and Backer, {Jonathan M.} and Williams, {Roger L.}",
year = "2007",
month = "7",
day = "13",
doi = "10.1126/science.1135394",
language = "English (US)",
volume = "317",
pages = "239--242",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "5835",

}

TY - JOUR

T1 - Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit

AU - Miled, Nabil

AU - Yan, Ying

AU - Hon, Wai Ching

AU - Perisic, Olga

AU - Zvelebil, Marketa

AU - Inbar, Yuval

AU - Schneidman-Duhovny, Dina

AU - Wolfson, Haim J.

AU - Backer, Jonathan M.

AU - Williams, Roger L.

PY - 2007/7/13

Y1 - 2007/7/13

N2 - Many human cancers involve up-regulation of the phosphoinositide 3-kinase PI3Ka, with oncogenic mutations identified in both the p110α catalytic and the p85α regulatory subunits. We used crystallographic and biochemical approaches to gain insight into activating mutations in two noncatalytic p110α domains - the adaptor-binding and the helical domains. A structure of the adaptor-binding domain of p110α in a complex with the p85α inter-Src homology 2 (inter-SH2) domain shows that oncogenic mutations in the adaptor-binding domain are not at the inter-SH2 interface but in a polar surface patch that is a plausible docking site for other domains in the holo p110/p85 complex. We also examined helical domain mutations and found that the Glu 545 to Lys545 (E545K) oncogenic mutant disrupts an inhibitory charge-charge interaction with the p85 N-terminal SH2 domain. These studies extend our understanding of the architecture of PI3Ks and provide insight into how two classes of mutations that cause a gain in function can lead to cancer.

AB - Many human cancers involve up-regulation of the phosphoinositide 3-kinase PI3Ka, with oncogenic mutations identified in both the p110α catalytic and the p85α regulatory subunits. We used crystallographic and biochemical approaches to gain insight into activating mutations in two noncatalytic p110α domains - the adaptor-binding and the helical domains. A structure of the adaptor-binding domain of p110α in a complex with the p85α inter-Src homology 2 (inter-SH2) domain shows that oncogenic mutations in the adaptor-binding domain are not at the inter-SH2 interface but in a polar surface patch that is a plausible docking site for other domains in the holo p110/p85 complex. We also examined helical domain mutations and found that the Glu 545 to Lys545 (E545K) oncogenic mutant disrupts an inhibitory charge-charge interaction with the p85 N-terminal SH2 domain. These studies extend our understanding of the architecture of PI3Ks and provide insight into how two classes of mutations that cause a gain in function can lead to cancer.

UR - http://www.scopus.com/inward/record.url?scp=34447503808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447503808&partnerID=8YFLogxK

U2 - 10.1126/science.1135394

DO - 10.1126/science.1135394

M3 - Article

VL - 317

SP - 239

EP - 242

JO - Science

JF - Science

SN - 0036-8075

IS - 5835

ER -